Ex vivo microvesicle formation after prolonged ischemia in renal transplantation

Thrombosis Research

Volumn 120, Issue 2, 2007, Pages 231-236

  Schuerholz, Tobias ^a   Weißig, Annette ^b   Juettner, Bjoern ^b   Becker, Thomas ^b   Scheinichen, Dirk ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Hemostasis; In vitro; Kidney transplantation; Platelet aggregation; Platelet membrane glycoproteins

Indexed keywords

ADENOSINE DIPHOSPHATE; CREATININE; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6;

ADULT; ANESTHESIA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOPRESERVATION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GRAFT PRESERVATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMED CONSENT; KIDNEY TRANSPLANTATION; MALE; MICROVESICLE FORMATION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ADENOSINE DIPHOSPHATE; ADULT; BLOOD PLATELETS; COLD; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; TIME FACTORS;

EID: 34248587909     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.10.003     Document Type: Article

References (22)

1. Bazilinski N., Shaykh M., and Dunea G. Inhibition of platelet function by uremic middle molecules. Nephron (1985) 423
2. Gawaz M.P., Mujais S.K., Schmidt B., and Gurland H.J. Platelet-leukocyte aggregation during hemodialysis. Kidney Int 2 (1994) 489-495
3. Diaz-Ricart M., Estebanell E., Cases A., Calls J., Lopez-Pedret J., Carretero M., et al. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling. Kidney Int 5 (2000) 1905-1914
4. Heijnen H.F.G., Schiel A.E., Fijnheer R., Geuze H.J., and Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 11 (1999) 3791-3799
5. Tans G., Rosing J., Thomassen M.C., Heeb M.J., Zwaal R.F., and Griffin J.H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood (1991) 2641
6. McGill M., Fugman D.A., Vittorio N., and Darrow C. Platelet membrane microvesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med (1987) 127-133
7. Howard M.A., Coghlan M., David R., and Pfueller S.L. Coagulation activities of plasma microparticles. Thromb Res (1988) 145-156
8. Abrams C.S., Ellison N., Budzynski A.Z., and Shattil S.J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1 (1990) 128-138
9. Owens M.R., Holme S., and Cardinali S. Platelet microvesicles adhere to subendothelium and promote adhesion of platelets. Thromb Res 2-3 (1992) 247-258
10. Gawaz M. Blood platelets (2001), Thieme, Stuttgart
11. Larsson A., Lundahl T., Eriksson M., Lundkvist K., and Lindahl T. Endotoxin induced platelet microvesicle formation measured by flow cytometry. Platelets (1996) 153-158
12. Holme P.A., Solum N.O., Brosstad F., Roger M., and Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost 5 (1994) 666-671
13. Koo D.D., Welsh K.I., Roake J.A., Morris P.J., and Fuggle S.V. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 2 (1998) 557-566
14. Ojo A.O., Wolfe R.A., Held P.J., Port F.K., and Schmouder R.L. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 7 (1997) 968-974
15. Scheinichen D., zu Vilsendorf A.M., Weissig A., Bornscheuer A., Becker T., Juettner B., et al. Reduced P-selectin expression on circulating platelets after prolonged cold preservation in renal transplantation. Clin Transplant 5 (2003) 444-450
16. Trotter J. WinMDI 2.8. Scripps Research Institute, La Jolla, CA, USA.
17. Jy W., Horstman L.L., Arce M., and Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 4 (1992) 334-345
18. Holme P.A., Solum N.O., Brosstad F., Egberg N., and Lindahl T.L. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa. Thromb Haemost 6 (1995) 1533-1540
19. Brass L.F., Manning D.R., Cichowski K., and Abrams C.S. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost 1 (1997) 581-589
20. Offermanns S. The role of heterotrimeric G proteins in platelet activation. Biol Chem 5-6 (2000) 389-396
21. Fong J.S., and Kaplan B.S. Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion". Blood 3 (1982) 564-570
22. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., and Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 29 (1989) 17049-17057